Answers are grounded in this paper and cite their sources.
ECPELLA (VA ECMO plus Impella 5.5) can provide escalated mechanical circulatory support for patients with refractory cardiogenic shock undergoing high-risk VT ablation, though overall prognosis in such extreme cases may remain poor.
In advanced heart failure, refractory hemodynamically unstable ventricular tachycardia (VT) can be life-threatening. The utilization of short-term temporary mechanical circulatory support (MCS) has been described. Still, it is limited to the intra-aortic balloon pump (IABP) or Impella 2.5/CP (Abiomed Inc., Danvers, MA, USA) which may only provide up to 1-2.5 L/min of added support. Escalation of MCS therapies should be considered. Referrals to advanced tertiary heart transplant centers should be done early to afford patients the best chance at an optimal outcome, with the option for heart transplant evaluation if needed. We present a case of recalcitrant hemodynamically unstable VT complicated by cardiac arrest, eventually undergoing successful VT ablation while supported on veno-arterial extracorporeal membrane oxygenation (VA ECMO) and Impella 5.5 as a vent strategy in the extracorporeal membrane oxygenation-Impella (ECPELLA) configuration.
No takes yet. Share an insight, caveat, or question.
Rajak et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: